FOXP3 and neoplasm: This is antithetical to the evidence that intra-tumor TGFβ is supposed to imprint a tolerogenic phenotype in antigen-presenting cells (mainly dendritic cells), which in turn migrate in peripheral lymphoid tissues to drive FoxP3+ Tregs commitment [26].